Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium

Delayed enhancement MRI using extracellular contrast media allows reliable detection of myocardial infarction. If blood pool contrast media like P792 (Vistarem, Guerbet, France), in addition to improving coronary MR angiography, can be shown to also produce delayed enhancement in myocardial infarction they could improve the prerequisites for a comprehensive cardiac MR examination. In this study reperfused myocardial infarction in five minipigs was imaged with an inversion‐recovery fast low‐angle shot sequence using P792 (0.013 mmol Gd/kg) and the extracellular contrast medium Gd‐DOTA (Dotarem, 0.1 mmol Gd/kg, Guerbet). The infarction size determined on MRI using P792 (7.55 ± 2.31 cm2) highly correlated both with histomorphometry (7.81 ± 2.18 cm2, r = 0.991, P < 0.002) and with MRI using Gd‐DOTA (7.85 ± 2.35 cm2, r = 0.978, P < 0.005). Bland‐Altman analysis showed that the limit of agreement of MRI using P792 compared to histomorphometry was 3.3 ± 7.6% of the infarction size. The contrast‐to‐noise ratio between infarcted and remote myocardium was not significantly different between Gd‐DOTA (5.9 ± 2.4) and P792 (4.4 ± 1.1, P = 0.5). The blood pool contrast medium P792 allows reliable assessment of viability with good contrast and accuracy. Magn Reson Med 51:703–709, 2004. © 2004 Wiley‐Liss, Inc.

[1]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[2]  B. Hamm,et al.  Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. , 2002, Radiology.

[3]  Wolfgang Ebert,et al.  Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits. , 2002, Journal of the American College of Cardiology.

[4]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[5]  Han Wen,et al.  Does binding of Gd‐DTPA to myocardial tissue contribute to late enhancement in a model of acute myocardial infarction? , 2003, Magnetic resonance in medicine.

[6]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[7]  C. Higgins,et al.  Magnetic Resonance Characterization of the Peri-Infarction Zone of Reperfused Myocardial Infarction With Necrosis-Specific and Extracellular Nonspecific Contrast Media , 2001, Circulation.

[8]  R. Peshock,et al.  Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. , 1988, Journal of the American College of Cardiology.

[9]  C. Higgins,et al.  Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. , 1999, Radiology.

[10]  J Keegan,et al.  Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography , 1999, Journal of magnetic resonance imaging : JMRI.

[11]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[12]  Imaging Time After Gd-DTPA Injection Is Critical in Using Delayed Enhancement to Determine Infarct Size Accurately With Magnetic Resonance Imaging , 2002 .

[13]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.

[14]  E. McVeigh,et al.  Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.

[15]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[16]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[17]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[18]  Debiao Li,et al.  Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. , 2001, Radiology.

[19]  Joon Beom Seo,et al.  MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model. , 2003, Radiology.

[20]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[21]  J. Oshinski,et al.  Imaging Time After Gd-DTPA Injection Is Critical in Using Delayed Enhancement to Determine Infarct Size Accurately With Magnetic Resonance Imaging , 2001, Circulation.

[22]  H. Lamb,et al.  Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs. , 2003, Radiology.

[23]  R. Jennings,et al.  Development of cell injury in sustained acute ischemia. , 1990, Circulation.

[24]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[25]  M. Port,et al.  Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography. , 2000, Investigative radiology.

[26]  R. Kim,et al.  Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. , 2000, Journal of the American College of Cardiology.

[27]  Maythem Saeed,et al.  MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide. , 2002, Radiology.

[28]  Sebastian Flacke,et al.  Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. , 2003, Radiology.

[29]  Wolfgang G Rehwald,et al.  Myocardial Magnetic Resonance Imaging Contrast Agent Concentrations After Reversible and Irreversible Ischemic Injury , 2002, Circulation.

[30]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[31]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[32]  John P Ridgway,et al.  Coronary artery disease: assessment with a comprehensive MR imaging protocol--initial results. , 2002, Radiology.

[33]  B. Hamm,et al.  Coronary magnetic resonance angiography: Experimental evaluation of the new rapid clearance blood pool contrast medium P792 , 2001, Magnetic resonance in medicine.

[34]  R. Dolan,et al.  Three‐dimensional MRI of coronary arteries using an intravascular contrast agent , 1998, Magnetic resonance in medicine.